Author

K. Surmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Organism:bacteria (other)· 1 Organism:C. elegans· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

U. Volker· 2 shared A. Becker· 1 shared A. Kirschbaum· 1 shared A. L. Jung· 1 shared A. Wesener· 1 shared B. J. Benedikter· 1 shared B. Klabunde· 1 shared B. Schmeck· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

U. Volker

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Podocyte exopher-formation as a novel pathomechanism in membranous nephropathy

K. Lahme, W. Sachs, S. Froembling, M. Brehler, D. Loreth, K. Surmann, S. Gaffling, U. Wedekind, V. Boettcher-Dierks, M. R. Adler, P. J. Saez, C. Conze, R. Thuenauer, S. Skuza, K. Neitzel, , C. Meyer-Schwesinger

This study identifies podocyte exopher-formation as a novel mechanism for removing antigen/autoantibody aggregates in membranous nephropathy, with potential for non-invasive monitoring.

bioRxiv · Apr 4, 2024 · PreprintCell Biology

Multi-omics investigations uncover unique pathogenic markers in clinical Klebsiella pneumoniae that could be leveraged as novel antimicrobial targets

L.-S. Swiatek, K. Surmann, E. Eger, J. U. Muller, M. G. Salazar, S. Guenther, G. Werner, N.-O. Hubner, J. A. Bohnert, K. Becker, S. E. Heiden, U. Volker, M. Schwabe, K. Schaufler

This study identifies unique pathogenic markers in Klebsiella pneumoniae through multi-omics analysis, suggesting potential novel antimicrobial targets.

bioRxiv · Dec 22, 2023 · PreprintMicrobiology

NAD+ metabolism is a key modulator of bacterial respiratory epithelial infections

B. Klabunde, A. Wesener, W. Bertrams, I. Beinborn, N. Paczia, K. Surmann, S. Blankenburg, J. Wilhelm, J. Serrania, K. Knoops, E. M. Elsayed, K. Laakmann, A. L. Jung, A. Kirschbaum, M. Abu Mraheil, , B. Schmeck

The paper investigates how NAD+ metabolism affects bacterial respiratory infections, finding that modulating NAD+ levels impacts both host and bacterial outcomes.

bioRxiv · Apr 13, 2023Immunology